1. Home
  2. NP vs IDYA Comparison

NP vs IDYA Comparison

Compare NP & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neptune Insurance Holdings Inc.

NP

Neptune Insurance Holdings Inc.

HOLD

Current Price

$31.71

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$36.30

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NP
IDYA
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.6B
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
NP
IDYA
Price
$31.71
$36.30
Analyst Decision
Buy
Strong Buy
Analyst Count
12
16
Target Price
$28.17
$52.86
AVG Volume (30 Days)
714.3K
691.4K
Earning Date
04-22-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.90
EPS
0.16
N/A
Revenue
N/A
$218,710,000.00
Revenue This Year
$25.84
N/A
Revenue Next Year
$15.80
$201.05
P/E Ratio
$200.56
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$14.78
$23.23
52 Week High
$35.15
$40.58

Technical Indicators

Market Signals
Indicator
NP
IDYA
Relative Strength Index (RSI) 52.25 52.85
Support Level $23.52 $33.23
Resistance Level $34.43 $37.82
Average True Range (ATR) 1.57 1.17
MACD -0.13 -0.04
Stochastic Oscillator 25.78 60.91

Price Performance

Historical Comparison
NP
IDYA

About NP Neptune Insurance Holdings Inc.

Neptune Insurance Holdings Inc is a high-growth, profitable, data-driven MGA that offers residential and commercial insurance products, including primary flood insurance, excess flood insurance and parametric earthquake insurance, distributed through a nationwide network of agencies in the United States. The company underwrites and administers the issuance of insurance policies on behalf of a diverse panel of insurance and reinsurance companies and does not take any balance sheet insurance risk or have claims handling responsibility relating to the policies it sells.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: